Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial (Q45422276)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial (English)

1 reference

Europe PubMed Central

14 December 2017

0 references

revascularization

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

14 December 2017

Stephan Windecker

17

object named as

Stephan Windecker

1 reference

Europe PubMed Central

14 December 2017

16

object named as

Peter Jüni

1 reference

Europe PubMed Central

14 December 2017

Peter Wenaweser

15

object named as

Peter Wenaweser

1 reference

Europe PubMed Central

14 December 2017

14

object named as

Franz R Eberli

1 reference

Europe PubMed Central

14 December 2017

3

object named as

Marco Roffi

1 reference

Europe PubMed Central

14 December 2017

7

object named as

Stéphane Cook

1 reference

Europe PubMed Central

14 December 2017

Aris Moschovitis

12

object named as

Aris Moschovitis

1 reference

Europe PubMed Central

14 December 2017

André Vuilliomenet

6

object named as

André Vuilliomenet

1 reference

Europe PubMed Central

14 December 2017

Daniel Weilenmann

8

object named as

Daniel Weilenmann

1 reference

Europe PubMed Central

14 December 2017

Peiman Jamshidi

10

object named as

Peiman Jamshidi

1 reference

Europe PubMed Central

14 December 2017

2

object named as

Dik Heg

1 reference

Europe PubMed Central

14 December 2017

4

object named as

David Tüller

1 reference

Europe PubMed Central

14 December 2017

5

object named as

Olivier Muller

1 reference

Europe PubMed Central

14 December 2017

Christoph J O Kaiser

9

object named as

Christoph Kaiser

1 reference

Europe PubMed Central

14 December 2017

author name string

Therese Fahrni

11

1 reference

Europe PubMed Central

14 December 2017

Stéphane Noble

13

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

1 September 2014

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

384

1 reference

Europe PubMed Central

14 December 2017

2111-2122

1 reference

Europe PubMed Central

14 December 2017

9960

1 reference

Europe PubMed Central

14 December 2017

Drug-eluting coronary-artery stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatmen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-E

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year outcome of a randomized trial comparing second-generation drug-eluting stents using biodegradable or durable polymer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomize

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical investigation into the observation that silicon carbide coating on cobalt chromium stents leads to early differentiating functional endothelial layer, increased safety and DES-like recurrent stenosis rates: results of the PRO-Heal Registry (

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines on myocardial revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Universal definition of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-eluting versus bare-metal stents in large coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961038-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(14)61038-2

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45422276&oldid=2076917194"